Login
No login? Register now to unlock hella tokens
No login? Register now to unlock hella tokens
Log In person
Salarius Pharmaceuticals Inc logo
Salarius Pharmaceuticals Inc SLRX
summarize 1 total product line
calendar_month Revenue as of 12/31/2019
Reporting Segmentarrow_drop_up Product Line Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Epigenetic-based Cancer Treatments
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
3.47M 100.00%
keyboard_arrow_right keyboard_arrow_down
Epigenetic-based Cancer Treatments
Pre-Revenue Pharmaceuticals
3.47M 100.00%
keyboard_arrow_right
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.